Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia

Amy Crowe(St Vincent's Hospital Melbourne), Rob Baird(Royal Darwin Hospital), Nicole McMahon(Royal Darwin Hospital), Bart J. Currie(Charles Darwin University)
International Journal of Antimicrobial Agents
May 28, 2014
10.1016/j.ijantimicag.2014.04.012
Cited by 61

Related Papers

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance
|JAMA|2018|779
The Epidemiology and Clinical Spectrum of Melioidosis: 540 Cases from the 20 Year Darwin Prospective Study
|PLoS neglected tropical diseases|2010|759
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study
|Clinical Infectious Diseases|2020|159
Changing epidemiology of candidaemia in Australia
|Journal of Antimicrobial Chemotherapy|2016|156
Changing epidemiology of candidaemia in Australia
|Journal of Antimicrobial Chemotherapy|2017|146